T-Cell Tolerant Fraction Can Predict Immunotherapy Toxicity
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 21, 2023 -- The T-cell tolerant fraction predicts clinically significant immune-related adverse events (irAEs) among patients with cancer treated with immune checkpoint inhibitors (ICIs), according to a study published in the August issue of the Journal for ImmunoTherapy of Cancer.
Jared Ostmeyer, Ph.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues examined T-cell receptor beta (TRB) locus sequencing from baseline pretreatment samples in 77 patients with cancer from an institutional registry (22 patients) and published studies (55 patients) receiving ICI therapy. TRB sequences for each patient were used to calculate the T-cell tolerant fraction, which was then examined as a predictor of future irAEs. The tolerant fraction was compared to TRB clonality and diversity.
The researchers found that cases with clinically significant irAEs had a significantly lower tolerant fraction and had an area under the receiver operating characteristic curve (AUC) of 0.79. From each ICI treatment category, the tolerant fraction was lower, reaching statistical significance for CTLA4. For T cells enriched against napsin A, a potential autoantigen of irAEs, the tolerant fraction was lower than other samples. In addition, thymic versus peripheral blood samples had a lower tolerant fraction, and the fraction was lower in some but not other autoimmune diseases (multiple sclerosis and type 1 diabetes, respectively). For predicting irAEs, TRB clonality and TRB diversity had AUCs of 0.62 and 0.60, respectively.
"In contrast to dynamic T cell clonal expansion or diversification, the tolerant fraction may be determined prior to ICI initiation, thereby potentially informing up-front selection of patients, treatments, and monitoring," the authors write.
One author disclosed ties to Amgen; several authors reported a U.S. patent application.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
ADA: Inhaled Insulin Shows Promise for Adults With Type 1 Diabetes
THURSDAY, June 27, 2024 -- Inhaled insulin is associated with improved hemoglobin A1c (HbA1c) levels over 16 weeks among adults with type 1 diabetes when compared to usual care...
1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...
Men Face More Diabetes Complications Than Women
FRIDAY, May 17, 2024 -- Men with diabetes have a greater risk for complications than women, irrespective of diabetes duration, according to a study published online May 16 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.